Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis-Reference-Cited by-同舟云学术

Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis

Published:2009-07 Issue:1-2 Volume:282 Page:112-119
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Horakova Dana,Dwyer Michael G.,Havrdova Eva,Cox Jennifer L.,Dolezal Ondrej,Bergsland Niels,Rimes Brett,Seidl Zdeněk,Vaneckova Manuela,Zivadinov Robert

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference54 articles.

1. Axonal transection in the lesions of multiple sclerosis;Trapp;N Engl J Med,1998

2. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis;Lublin;Neurology,1996

3. Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision;Bergamaschi;Expert Rev Neurother,2006

4. Clinical-magnetic resonance imaging correlations in multiple sclerosis;Zivadinov;J Neuroimaging,2005

5. Imaging of multiple sclerosis: role in neurotherapeutics;Bakshi;NeuroRx,2005

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis;Journal of Neurology;2024-06-23

2. Updated Study Data for Ozanimod in Relapsing Multiple Sclerosis;American Medical Journal Neurology;2024-05-30

3. MRI features and disability in multiple sclerosis: A systematic review and meta-analysis;Journal of Neuroradiology;2024-02

4. Prevalence of 2-year “No evidence of disease activity” (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study;Multiple Sclerosis and Related Disorders;2023-11

5. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis;PLOS ONE;2023-07-28